Cetera Investment Advisers
KRTX

Cetera Investment Advisers’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Cetera Investment Advisers’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,037
Closed -$328K – 3738
2023
Q4 		$328K Buy
+1,037
New +$202K ﹤0.01% 1738

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Cetera Investment Advisers's KRTX Position: Q1 2024 in Review

Cetera Investment Advisers sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 1,037 shares — an estimated $328K sold.

Cetera Investment Advisers first reported a position in KRTX in Q4 2023 and held it in 1 quarter. The position peaked at $328K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Cetera Investment Advisers reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Cetera Investment Advisers sold 1,037 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $328K.
  • Cetera Investment Advisers first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • Cetera Investment Advisers's Karuna Therapeutics, Inc. Common Stock position peaked at $328K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Cetera Investment Advisers's 13F filing for Q1 2024, filed 15 May 2024.